CIK 0001649904 · Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462159271
- Phone
- 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,753,355
- in 2 filings, $11.8M under 10b5-1 plans
Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-03 | MCGIRR DAVID W J Director | Sale 10b5-1 | −9,873 | $65.64 | $648K | 3,000 |
| 2025-06-03 | MCGIRR DAVID W J Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −65,431 | 0 | ||
| 2025-06-03 | Meeker David P President and CEO | Option exercise 10b5-1 | +43,620 | $4.59 | $200K | 245,445 |
| 2025-06-03 | Meeker David P President and CEO | Sale 10b5-1 | −43,346 | $65.04 | $2.8M | 202,099 |
| 2025-06-03 | Meeker David P President and CEO | Sale 10b5-1 | −274 | $65.60 | $18K | 201,825 |
| 2025-06-03 | Meeker David P President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −43,620 | 0 | ||
| 2025-05-30 | Smith Hunter C Chief Financial Officer | Option exercise 10b5-1 | +23,400 | $6.88 | $161K | 133,329 |
| 2025-05-30 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −4,407 | $60.93 | $269K | 128,922 |
| 2025-05-30 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −18,993 | $61.52 | $1.2M | 109,929 |
| 2025-05-30 | Smith Hunter C Chief Financial Officer | Option exercise · Stock Options (Right to Buy) 10b5-1 | −23,400 | 77,194 | ||
| 2025-04-29 | Cramer Pamela J. Chief Human Resources Officer | Option exercise 10b5-1 | +7,031 | $6.80 | $48K | 26,240 |
| 2025-04-29 | Cramer Pamela J. Chief Human Resources Officer | Sale 10b5-1 | −7,031 | $65.09 | $458K | 19,209 |
| 2025-04-29 | Cramer Pamela J. Chief Human Resources Officer | Option exercise · Stock Options (Right to Buy) 10b5-1 | −7,031 | 35,159 | ||
| 2025-04-29 | Mazabraud Yann EVP, Head of International | Sale 10b5-1 | −6,745 | $65.08 | $439K | 37,655 |
| 2025-04-15 | Mazabraud Yann EVP, Head of International | Option exercise | +11,405 | 44,400 | ||
| 2025-04-15 | Mazabraud Yann EVP, Head of International | Option exercise · Restricted Stock Units | −8,905 | 0 | ||
| 2025-04-15 | Mazabraud Yann EVP, Head of International | Option exercise · Restricted Stock Units | −2,500 | 7,500 | ||
| 2025-04-14 | Mazabraud Yann EVP, Head of International | Option exercise | +10,375 | 32,995 | ||
| 2025-04-14 | Mazabraud Yann EVP, Head of International | Option exercise · Restricted Stock Units | −10,375 | 20,750 | ||
| 2025-04-08 | Cramer Pamela J. Chief Human Resources Officer | Option exercise 10b5-1 | +14,060 | $6.80 | $96K | 33,269 |
Page 15 of 19 · 376 trades